A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes.

By B. Willing, J. Dicksved, J. Halfvarson, Anders F. Andersson, M. Lucio, Zongli Zheng, G. Järnerot, C. Tysk, Janet K. Jansson, L. Engstrand. Gastroenterology, 2010

1,037 citations recorded by the source corpus.

Subfields: Genetics, Infectious Diseases, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/17de69082e4f0ea3245e17f45b8067072a5c9603

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. Jeroen Raes
2. Karsten Kristiansen
3. Ruth E. Ley
4. Sunil K. Lal
5. Peer Bork
6. J. Walter
7. Z. Y. Kho
8. M. Pateiro

In Infectious Diseases

1. J. Walter
2. F. Bäckhed
3. Ruth E. Ley
4. M. Pateiro
5. Jeffrey I. Gordon

In Molecular Biology

1. F. Bäckhed
2. J. Walter
3. Ruth E. Ley
4. Jeroen Raes
5. V. Tremaroli
6. C. Belzer
7. Peer Bork
8. Liping Zhao

Citations in the corpus

• Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome (2019, background): “Human Faecalibacterium and Roseburia Enterobacteriaceae and Ruminococcus gnavus Decrease Increase [52]”
• Dirichlet Multinomial Mixtures: Generative Models for Microbial Metagenomics (2012, methodology): “We also include a brief analysis of microbiome data from a study of inflammatory bowel diseases (IBDs) [28].”
• Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model (2012, background): “…cluster XIVa4 Lachnospiraceae family), over Bacteroidetes in biopsies compared with luminal or faecal samples, both in rodents (Hill et al., 2009; Nava et al., 2011) and humans (Eckburg et al., 2005; Frank et al., 2007; Shen et al., 2010; Wang et al., 2010; Willing et al., 2010; Hong et al., 2011).”
• How informative is the mouse for human gut microbiota research? (2015, background): “, 2008) or in the abundance of Roseburia (Willing et al., 2010) were found only in human Crohn’s disease studies.”
• Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach (2017, background): “At lower taxonomic levels, the abundance of Coriobacteriaceae, which has been linked to chronic tissue inflammation and is increased in patients with colononly Crohn’s disease,((31)) was higher in patients with NAFLD than CTRLs.”